Ziehfreund, Stefanie
Tizek, Linda
Arkema, Elizabeth V.
Zink, Alexander
Funding for this research was provided by:
Technische Universität München
Article History
Received: 16 February 2024
Accepted: 1 August 2024
First Online: 20 August 2024
Competing interests
: EVA reported no conflict of interest SZ has received grants from Novartis LT currently works for ViiV Healthcare and has received speaker’s honoraria and/or grants from Novartis and Jassen Cilag. AZ has been an advisor and/or received speaker's honoraria and/or received grants and/or participated in clinical trials of the following companies: AbbVie, Almirall, Amgen, Beiersdorf Dermo Medical, Bencard Allergie, BMS, Celgene, Eli Lilly, GSK, Janssen Cilag, Leo Pharma, Miltenyi Biotec, Novartis, Pfizer, Sanofi-Aventis, Takeda Pharma, UCB Pharma.